Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014 (2014), Article ID 597164, 9 pages
http://dx.doi.org/10.1155/2014/597164
Research Article

Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials

1Department of Otolaryngology, Division of Head and Neck Cancer Research, School of Medicine, The Johns Hopkins University, Baltimore, MD 21231, USA
2Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD 21205, USA
3Laboratorio de Patología Molecular, Departamento de Anatomí a Patológica, CEGIN-BIOREN, Facultad de Medicina, Universidad de La Frontera, 4781176 Temuco, Chile
4Department of Gastroenterology, School of Medicine, The Johns Hopkins University, Baltimore, MD 21205, USA
5Department of Pathology, School of Medicine, The Johns Hopkins University, Baltimore, MD 21205, USA
6Bellvitge Biomedical Research Institute, Barcelona, Catalonia, Spain
7Department of Obstetrics and Gynecology, University of Puerto Rico School of Medicine, San Juan, PR 00927, USA

Received 3 December 2013; Revised 4 February 2014; Accepted 7 February 2014; Published 17 April 2014

Academic Editor: Ronghua Zhao

Copyright © 2014 Christina Michailidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Table 1: lists the quantitative Methylation Specific PCR (qMSP) primers and probes used in this manuscript to quantify promoter methylation of RASSF1A, SSBP42, B4GALT1 and ACTB.

  1. Supplementary Table